Huong Thien Nguyen MD

Assistant Professor, Hematology & Oncology
Internal Medicine, Hematology & Oncology
Clinical Interests:

myelopfoliferative neoplasms


U of M Hematology

Cancer Center Floor B1 Reception B
1500 E Medical Center Dr SPC 5911
Ann Arbor


Medical School or Training

  • Stanford University School of Medicine, 2006


  • University of Washington Medical Center, Internal Medicine, WA, 2009


  • Hematology/Oncology, Stanford University School of Medicine, 2013

Professional Organizations

  • American Society of Hematology

  • American society of Clinical Oncology

  • American Association for Cancer Research

  • SWOG (formerly Southwest Oncology Group) 

  • Society of Hematologic Oncology

Board Certification

  • Internal Medicine


Dr. Nguyen’s research is focused on developing novel therapy to treat myeloproliferative neoplasms, particularly for patients with myelofibrosis and mast cell disease. Dr. Nguyen is currently leading the development at the University of Michigan of PI3K inhibitors for myelofibrosis and other targeted therapies for myeloproliferative neoplasms in phase I/II clinical trials. 


Dr. Marie Huong Nguyen completed her undergraduate degrees (B.A. in Classics- Ancient History and B.S. in Biological Sciences) at Stanford University where she graduated with Honors and Distinction in both fields. She was also awarded the Robert M. Golden Medal for Excellence in the Humanities for her Classics thesis work. She then obtained her M.D. from Stanford School of Medicine as part of the Stanford Medical Scholars Program, performing Epidemiology Infectious Diseases Research with Dr. Julie Parsonnet. Dr. Nguyen completed her Internal Medicine residency training at the University of Washington in Seattle, where she first became interested in Hematology through evaluating heme transport in the lab of Dr. Jan Abkowitz as an American Society of Hematology (ASH) Trainee Awardee. Dr. Nguyen then returned to Stanford where she completed her Hematology/Oncology Fellowship. During her fellowship, she was elected to the ASH Trainee Council where she eventually served as Chair. Under the mentorship of Dr. Jason Gotlib at Stanford, Dr. Nguyen subspecialized in treating patients with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), chronic myeloid leukemia (CML), chronic myelomonocytic leukemia (CMML), hypereosinophilic syndromes, and systemic mastocytosis and mast cell disease. As Assistant Professor in Internal Medicine (Hematology/Oncology) at the University of Michigan Comprehensive Cancer Center, Dr. Nguyen is focused on developing novel clinical trials for the treatment of MPNs.